Cephalosporin Nitrogen Mustard Carbamate prodrugs for “ADEPT”.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Tetrahedron Letters

• Publication date

  1991-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0040-4039(00)79741-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cephalosporin 3'-quinolone esters with a dual mode of action.

  1990cited by this paper
• Single-pot reductive conversion of amino acids to their respective 2-oxazolidinones employing trichloromethyl chloroformate as the acylating agent: a multigram synthesis

  1989cited by this paper
• Antibody directed enzymes revive anti-cancer prodrugs concept.

  1987cited by this paper
• Triphosgene, a Crystalline Phosgene Substitute

  1987cited by this paper
• STUDIES ON β-LACTAM ANTIBIOTICS

  1985cited by this paper
• Chemistry of cephalosporin antibiotics. XIX. Transformation of delta2-cephem to delta3-cephem by oxidation-reduction at sulfur.

  1970cited by this paper
• Use of p-nitrophenyl chloroformate in blocking hydroxyl groups in nucleosides.

  1967cited by this paper
• Cure of Mice bearing Advanced Plasma Cell Tumours with Aniline Mustard : the Relationship between Glucuronidase Activity and Tumour Sensitivity

  1966cited by this paper
• The Total Synthesis of Cephalosporin C1

  1966cited by this paper
• Cure of Mice Bearing Advanced Plasma Cell Tumours With Aniline Mustard

  1965cited by this paper
• Studies in Organophosphorus Chemistry. I. Conversion of Alcohols and Phenols to Halides by Tertiary Phosphine Dihalides

  1964cited by this paper

• Selective Drug Delivery Using Targeted Enzymes For Prodrug Activation

  2019cites this paper
• Engineering of Escherichia coli β-lactamase TEM-1 variants showing higher activity under acidic conditions than at the neutral pH.

  2018cites this paper
• Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.

  2018cites this paper
• Prodrugs in medicinal chemistry and enzyme prodrug therapies

  2017cites this paper
• Strategies in the designing of prodrugs, taking into account the antiviral and anticancer compounds.

  2017cites this paper
• Evaluation of wild type and mutants of β-Glucuronidase (GUS) against natural and synthetic substrates

  2014cites this paper
• The mechanism of guanine alkylation by nitrogen mustards: a computational study.

  2012cites this paper
• Directed Enzyme Prodrug Therapies

  2011cites this paper
• Identification of prodrug, active drug, and metabolites in an ADEPT clinical study

  2009cites this paper
• Design and synthesis of a beta-lactamase activated 5-fluorouracil prodrug.

  2009cites this paper
• Design and synthesis of novel N10 protected pyrrolobenzodiazepines for use in ADEPT and GDEPT

  2009cites this paper
• Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical study

  2007cites this paper
• Antibody-directed enzyme prodrug therapy (ADEPT) for cancer

  2006cites this paper
• jY-(4'-Hydroxyphenylacetyl)palytoxin: A Palytoxin Prodrug That Can Be Activated by a Monoclonal Antibody-Penicillin G Amidase Conjugate1

  2006cites this paper
• Design of prodrugs for suicide gene therapy.

  2004cites this paper
• Antibody-directed enzyme prodrug therapy (ADEPT) for cancer

  2004cites this paper
• Synthesis of beta-lactamase activated nitric oxide donors.

  2003cites this paper
• Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug

  2001cites this paper
• Cephalosporins containing carbonate functions at positions 3 and 7

  2000cites this paper
• Enzymes and Prodrugs Used for ADEPT

  1999cites this paper
• Developments with targeted enzymes in cancer therapy.

  1999cites this paper
• Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs.

  1999cites this paper
• Concept, design, and preclinical evaluation of quinolonyl lactam antibacterials.

  1998cites this paper
• New developments in the use of nitrogen mustard alkylating agents as anticancer drugs

  1998cites this paper
• Antibody-directed enzyme prodrug therapy (ADEPT): a review.

  1997cites this paper
• Antibody-enzyme conjugates for cancer therapy.

  1996cites this paper
• Alkylating agent prodrugs for ADEPT

  1996cites this paper
• Advanced drug delivery reviews : enzyme prodrug therapy

  1996cites this paper
• A summary of monoclonal antibody-enzyme/prodrug

  1996cites this paper
• AN-nitrosochloroethyl-cephalosporin carbamate prodrug for antibody-directed enzyme prodrug therapy (ADEPT)

  1996cites this paper
• Section Review: Biologicals & Immunologicals: Development of prodrugs for ADEPT (antibody-directed enzyme prodrug therapy)

  1996cites this paper
• Novel synthesis of 6,6-dibromo-2′-Z-chloromethyl and 2′-Z-bromomethyl anhydropenicllins from 6,6-dibromo 2β-(chloromethyl) and 2β-(bromomethyl)-2α-methyl-penam-3α-carboxylic acid via anhydropenicillin rearrangement

  1996cites this paper
• Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase.

  1995cites this paper
• Development of a humanized disulfide-stabilized anti-p185HER2 Fv-beta-lactamase fusion protein for activation of a cephalosporin doxorubicin prodrug.

  1995cites this paper
• Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs.

  1995cites this paper
• Site-specific prodrug activation by antibody-beta-lactamase conjugates: preclinical investigation of the efficacy and toxicity of doxorubicin delivered by antibody directed catalysis.

  1995cites this paper
• Antibody-directed enzyme prodrug therapy.

  1995cites this paper
• Antibody‐directed enzyme prodrug therapy: A review

  1995cites this paper
• Design and synthesis of an antitumor prodrug released by the reaction with sulfhydryl compounds

  1995cites this paper
• Synthesis and β-lactamase-mediated activation of a cephalosporin-taxol prodrug

  1995cites this paper
• Antibody-Directed Enzyme Prodrug Therapy

  1995cites this paper
• Virtual cofactors for an Escherichia coli nitroreductase enzyme: relevance to reductively activated prodrugs in antibody directed enzyme prodrug therapy (ADEPT).

  1995cites this paper
• Prodrugs in cancer chemotherapy

  1995cites this paper
• Targeting enzymes for cancer therapy: old enzymes in new roles.

  1994cites this paper
• Antibody-Directed Enzyme Prodrug Therapy

  1994cites this paper
• Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects.

  1994cites this paper
• Synthesis and characterization of monoclonal antibody-beta-lactamase conjugates.

  1994cites this paper
• Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates.

  1994cites this paper
• Generation of cytotoxic agents by targeted enzymes.

  1993cites this paper
• Synthesis and release of doxorubicin from a cephalosporin based prodrug by a β-lactamase-immunoconjugate

  1993cites this paper
• Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.

  1993cites this paper
• The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT)

  1993cites this paper
• Antitumor activities of a cephalosporin prodrug in combination with monoclonal antibody-beta-lactamase conjugates.

  1993cites this paper
• Monoclonal antibody-beta-lactamase conjugates for the activation of a cephalosporin mustard prodrug.

  1992cites this paper
• Metabolism of NAD(P)H by blood components. Relevance to bioreductively activated prodrugs in a targeted enzyme therapy system.

  1992cites this paper
• N-(4'-hydroxyphenylacetyl)palytoxin: a palytoxin prodrug that can be activated by a monoclonal antibody-penicillin G amidase conjugate.

  1992cites this paper
• Overview: Antibody-Directed Enzyme Prodrug Therapy (ADEPT) and its Application to Cancer Treatment

  1992cites this paper
• Activation of prodrugs by targeted enzymes.

  1991cites this paper
• Dérivés de 7-acyl-3-(carbamoyloxy substitué)-céphème, leur application et leur procédé de préparation

  1991cites this paper
• Optimization and Validation of  -lactamase Production by Bacillus cereus VITMUT using Response Surface Method and Artificial Neural Network

  year unknowncites this paper